Skip Navigation

NRG-BR008: A Phase III Randomized Trial Of Radiotherapy Optimization For Low-Risk HER2-POSITIVE Breast Cancer HERO

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05705401

Study #:
STUDY00150096

Start Date:
May 24, 2023

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05705401

View Complete Trial Details & Eligibility at ClinicalTrials.gov